New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2014
10:08 EDTCVSCVS Caremark sees 2014 share repurchases of $4B
CVS says that it is "well-positioned" for growth in a changing health care landscape. Says increased Medicaid enrollment will fuel its leading position in managed Medicaid. Sees 43M people enrolled in Medicaid enrollment by 2016. Says "well-positioned" to gain share in exchanges across the enterprise. Says overall growth in exchanges will be a net positive. Says focused on enhancing shareholder value through driving long-term growth, generating "significant" free cash flow and optimizing capital allocation. In terms of CAGR from FY13-FY18, CVS sees net revenue 9%-13%, sees operating profit 7%-9%, sees final adjusted EPS 10%-14%, sees share repurchase contribution 4%-6% and average annual cash available for enhancing shareholder value $7.5B-$8.5B. When discussing efficient cash deployment from FY14 through FY18, CVS says it will have $40B in cash available for enhancing shareholder value. Expects a target payout ratio for dividends during that time to be 35% by FY18 with 18% implied dividend CAGR. Expects a return on invested capital and says that it will drive ROIC with value-enhancing projects. Sees $4B-$5B of share repurchases per year through 2018. Comments taken from slides from CVS Caremark's presentation at the Wells Fargo Healthcare conference.
News For CVS From The Last 14 Days
Check below for free stories on CVS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
08:25 EDTCVSCVS Caremark earns first Community Pharmacy accreditation from URAC
Subscribe for More Information
July 30, 2014
09:00 EDTCVSMcKesson extends pharmaceutical distribution agreement with CVS Caremark
McKesson Corporation (MCK) announced a three-year extension of its existing distribution agreement with CVS Caremark (CVS) through June, 2019. “We have a long track record of delivering comprehensive supply chain solutions to CVS Caremark which in turn allows CVS Caremark to ensure the highest level of pharmaceutical care to its customers,” said Paul Julian, executive vice president, group president, McKesson Corporation. “We are pleased to have extended our agreement with CVS Caremark and continue our long standing partnership.”
July 29, 2014
07:55 EDTCVSLeerink a buyer of Catamaran ahead of Q2 results
Leerink says it's a buyer of Catamaran (CTRX) ahead of the company's Q2 results as it believes shares have more room to run. The firm is cautious on Express Scripts (ESRX) after hearing from a specialist that service challenges may impact the company's 2015 and 2016 selling seasons. The firm remains positive on CVS Caremark (CVS), but notes shares have outperformed and the company could see retail pressure from recent drug inflation trends.
July 28, 2014
12:21 EDTCVSOn The Fly: Midday Wrap
Subscribe for More Information
09:17 EDTCVSOn The Fly: Pre-market Movers
Subscribe for More Information
06:22 EDTCVSHorizon Pharma said Duexis, Vimovo to be placed on CVS, Express exlclusion lists
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use